1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Myxoid Liposarcoma Global Clinical Trials Review, H1, 2015

Myxoid Liposarcoma Global Clinical Trials Review, H1, 2015

  • February 2015
  • -
  • Global Data
  • -
  • 80 pages

Myxoid Liposarcoma Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Myxoid Liposarcoma Global Clinical Trials Review, H1, 2015" provides data on the Myxoid Liposarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myxoid Liposarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Myxoid Liposarcoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Myxoid Liposarcoma Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Myxoid Liposarcoma 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Myxoid Liposarcoma to Oncology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Myxoid Liposarcoma to Oncology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Myxoid Liposarcoma Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Johnson and Johnson 28
Clinical Trial Overview of Johnson and Johnson 28
F. Hoffmann-La Roche Ltd. 29
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 29
Eisai Co., Ltd. 30
Clinical Trial Overview of Eisai Co., Ltd. 30
CTI BioPharma Corp. 31
Clinical Trial Overview of CTI BioPharma Corp. 31
Clinical Trial Overview of Top Institutes / Government 32
Fred Hutchinson Cancer Research Center 32
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 32
Leiden University Medical Center 33
Clinical Trial Overview of Leiden University Medical Center 33
Vector Oncology 34
Clinical Trial Overview of Vector Oncology 34
The Alliance for Clinical Trials in Oncology 35
Clinical Trial Overview of The Alliance for Clinical Trials in Oncology 35
Fondazione IRCCS - Istituto Nazionale dei Tumori 36
Clinical Trial Overview of Fondazione IRCCS - Istituto Nazionale dei Tumori 36
Grupo Espanol de Investigacion en Sarcomas 37
Clinical Trial Overview of Grupo Espanol de Investigacion en Sarcomas 37
Istituto Nazionale per lo Studio e la Cura dei Tumori 38
Clinical Trial Overview of Istituto Nazionale per lo Studio e la Cura dei Tumori 38
European Organization for Research and Treatment of Cancer 39
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 39
Five Key Clinical Profiles 40
Appendix 77
Abbreviations 77
Definitions 77
Research Methodology 78
Secondary Research 78
About GlobalData 79
Contact Us 79
Disclaimer 79
Source 80

List of Tables
Myxoid Liposarcoma Therapeutics, Global, Clinical Trials by Region, 2015* 6
Myxoid Liposarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Myxoid Liposarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Myxoid Liposarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 9
Myxoid Liposarcoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 10
Myxoid Liposarcoma Therapeutics Clinical Trials, North America, Top Countries, 2015* 11
Myxoid Liposarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 12
Myxoid Liposarcoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 13
Proportion of Myxoid Liposarcoma to Oncology Clinical Trials, G7 Countries (%), 2015* 14
Myxoid Liposarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Myxoid Liposarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Myxoid Liposarcoma to Oncology Clinical Trials, E7 Countries (%), 2015* 17
Myxoid Liposarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Myxoid Liposarcoma Therapeutics, Global, Clinical Trials by Phase, 2015* 19
Myxoid Liposarcoma Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 20
Myxoid Liposarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21
Myxoid Liposarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 22
Myxoid Liposarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 23
Myxoid Liposarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 24
Myxoid Liposarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 25
Myxoid Liposarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 26
Myxoid Liposarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 27
Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2015* 28
Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 29
Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015* 30
Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by CTI BioPharma Corp., 2015* 31
Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2015* 32
Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2015* 33
Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Vector Oncology, 2015* 34
Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The Alliance for Clinical Trials in Oncology, 2015* 35
Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fondazione IRCCS - Istituto Nazionale dei Tumori, 2015* 36
Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Grupo Espanol de Investigacion en Sarcomas, 2015* 37
Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Istituto Nazionale per lo Studio e la Cura dei Tumori, 2015* 38
Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2015* 39

List of Figures
Myxoid Liposarcoma Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
Myxoid Liposarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Myxoid Liposarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Myxoid Liposarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 9
Myxoid Liposarcoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 10
Myxoid Liposarcoma Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 11
Myxoid Liposarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 12
Myxoid Liposarcoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 13
Proportion of Myxoid Liposarcoma to Oncology Clinical Trials, G7 Countries (%), 2015* 14
Myxoid Liposarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Myxoid Liposarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Myxoid Liposarcoma to Oncology Clinical Trials, E7 Countries (%), 2015* 17
Myxoid Liposarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Myxoid Liposarcoma Therapeutics, Global, Clinical Trials by Phase (%), 2015* 19
Myxoid Liposarcoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 20
Myxoid Liposarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21
Myxoid Liposarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 23
Myxoid Liposarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 24
Myxoid Liposarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 25
Myxoid Liposarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 26
Myxoid Liposarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 27
GlobalData Methodology 78

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.